| [1] |
齐文信，张瑞忠. 泡沫法检测豆角皂甙食物中毒的调查[J]. 检验医学与临床，2011，8(24)：3072.
|
| [2] |
Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease[J]. Prog Retin Eye Res, 2001, 20(2): 175-208.
|
| [3] |
You Y, Gupta VK, Li JC, et al. Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss[J]. Rev Neurosci, 2013, 24(3): 301-321.
|
| [4] |
Raichle ME, Gusnard DA. Appraising the brain′s energy budget[J]. Proc Natl Acad Sci USA, 2002, 99(16): 10237-10239.
|
| [5] |
Wang MY, Sadun AA. Drug-related mitochondrial optic neuro-pathies[J]. J Neuroophthalmol, 2013, 33(2): 172-178.
|
| [6] |
Sadun A. Acquired mitochondrial impairment as a cause of optic nerve disease[J]. Trans Am Ophthalmol Soc, 1998, 96：881-923.
|
| [7] |
Bristow EA, Griffiths PG, Andrews RM, et al. The distribution of mitochondrial activity in relation to optic nerve structure[J]. Arch Ophthalmol, 2002, 120(6): 791-796.
|
| [8] |
Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies--disease mechanisms and therapeutic strategies[J]. Prog Retin Eye Res, 2011, 30(2): 81-114.
|
| [9] |
Sitarz KS, Chinnery PF, Yu-Wai-Man P. Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets[J]. Curr Neurol Neurosci Rep, 2012, 12(3): 308-317.
|
| [10] |
Levin LA. Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas[J]. J Neuroophthalmol, 2015, 35(2): 152-160.
|
| [11] |
Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100，000 new cases of blindness each year[J]. J Neuroophthalmol, 2008, 28(4): 265-268.
|
| [12] |
Karnik AM, Al-Shamali MA,，Fenech FF. A case of ocular toxicity to ethambutol——an idiosyncratic reaction？[J]. Postgrad Med J, 1985, 61(719): 811-813.
|
| [13] |
Kozak SF, Inderlied CB, Hsu HY, et al. The role of copper on ethambutol′s antimicrobial action and implications for ethambutol-induced optic neuropathy[J]. Diagn Microbiol Infect Dis, 1998, 30(2): 83-87.
|
| [14] |
Chuenkongkaew W, Samsen P, Thanasombatsakul N. Ethambutol and optic neuropathy[J]. J Med Assoc Thai, 2003, 86(7): 622-625.
|
| [15] |
Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan[J]. Kaohsiung J Med Sci, 2015, 31(7): 358-362.
|
| [16] |
Chamberlain PD, Sadaka A, Berry S, et al. Ethambutol optic neuropathy[J]. Curr Opin Ophthalmol, 2017, 28(6): 545-551.
|
| [17] |
Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy[J]. J Ocul Pharmacol Ther, 1997, 13(5): 473-477.
|
| [18] |
Sivakumaran P, Harrison AC, Marschner J, et al. Ocular toxicity from ethambutol: a review of four cases and recommended precautions[J]. N Z Med J, 1998, 111(1077): 428-430.
|
| [19] |
Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy[J]. J Neuroophthalmol, 2011, 31(2): 121-126.
|
| [20] |
Osaguona VB, Sharpe JA, Awaji SA, et al. Optic chiasm involvement on MRI with ethambutol-induced bitemporal hemianopia[J]. J Neuroophthalmol, 2014, 34(2): 155-158.
|
| [21] |
Oliveira C. Toxic-metabolic and hereditary optic neuropathies[J]. Continuum (Minneap Minn), 2019, 25(5): 1265-1288.
|
| [22] |
Martin-Amat G, Tephly TR, McMartin KE, et al. Methyl alcohol poisoning. Ⅱ. Development of a model for ocular toxicity in methyl alcohol poisoning using the rhesus monkey[J]. Arch Ophthalmol, 1977, 95(10): 1847-1850.
|
| [23] |
Hayreh MS, Hayreh SS, Baumbach GL, et al. Methyl alcohol poisoning Ⅲ. Ocular toxicity[J]. Arch Ophthalmol, 1977, 95(10): 1851-1858.
|
| [24] |
Kute VB, Godara SM, Shah PR, et al. Hemodialysis for methyl alcohol poisoning: a single-center experience[J]. Saudi J Kidney Dis Transpl, 2012, 23(1): 37-43.
|
| [25] |
Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management[J]. Clin J Am Soc Nephrol, 2008, 3(1): 208-225.
|
| [26] |
Baumbach GL, Cancilla PA, Martin-Amat G, et al. Methyl alcohol poisoning. Ⅳ. Alterations of the morphological findings of the retina and optic nerve[J]. Arch Ophthalmol, 1977, 95(10): 1859-1865.
|
| [27] |
McKellar MJ, Hidajat RR, Elder MJ. Acute ocular methanol toxicity: clinical and electrophysiological features[J]. Aust N Z J Ophthalmol, 1997, 25(3): 225-230.
|
| [28] |
Jarwani BS, Motiani P, Divetia R, et al. Rare combination of bilateral putaminal necrosis, optic neuritis, and polyneuropathy in a case of acute methanol intoxication among patients met with hooch tragedy in Gujarat, India[J]. J Emerg Trauma Shock, 2012, 5(4): 356-359.
|
| [29] |
Hsu HH, Chen CY, Chen FH, et al. Optic atrophy and cerebral infarcts caused by methanol intoxication: MRI[J]. Neuroradiology, 1997, 39(3): 192-194.
|
| [30] |
Koopmans RA, Li DK,，Paty DW. Basal ganglia lesions in methanol poisoning: MR appearance[J]. J Comput Assist Tomogr, 1988, 12(1): 168-169.
|
| [31] |
Halavaara J, Valanne L, Setälä K. Neuroimaging supports the clinical diagnosis of methanol poisoning[J]. Neuroradiology, 2002, 44(11): 924-928.
|
| [32] |
Gaul HP, Wallace CJ, Auer RN, et al. MR findings in methanol intoxication[J]. AJNR Am J Neuroradiol, 1995, 16(9): 1783-1786.
|
| [33] |
Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning[J]. J Toxicol Clin Toxicol, 2002, 40(4): 415-446.
|
| [34] |
Shukla M, Shikoh I, Saleem A. Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning[J]. Indian J Ophthalmol, 2006, 54(1): 68-69.
|
| [35] |
Abrishami M, Khalifeh M, Shoayb M, et al. Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy[J]. J Ocul Pharmacol Ther, 2011, 27(3): 261-263.
|
| [36] |
Pakdel F, Sanjari MS, Naderi A, et al. Erythropoietin in Treatment of Methanol Optic Neuropathy[J]. J Neuroophthalmol, 2018, 38(2): 167-171.
|
| [37] |
Joshi L, Taylor SR, Large O, et al. A case of optic neuropathy after short-term linezolid use in a patient with acute lymphocytic leukemia[J]. Clin Infect Dis, 2009, 48(7): e73-e74.
|
| [38] |
Azamfirei L, Copotoiu SM, Branzaniuc K, et al. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy[J]. Pharmacoepidemiol Drug Saf, 2007, 16(4): 402-404.
|
| [39] |
Sotgiu G, Centis R, D′Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis[J]. Eur Respir J, 2012, 40(6): 1430-1442.
|
| [40] |
Bolhuis MS, van Altena R,，Alffenaar JW. Comment on: daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients[J]. J Antimicrob Chemother, 2012, 67(8): 2055-2056.
|
| [41] |
Rucker JC, Hamilton SR, Bardenstein D, et al. Linezolid-associated toxic optic neuropathy[J]. Neurology, 2006, 66(4): 595-598.
|
| [42] |
Lee E, Burger S, Shah J, et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases[J]. Clin Infect Dis, 2003, 37(10): 1389-1391.
|
| [43] |
Yu JJ, Lee DH, Gallagher SP, et al. Mitochondrial impairment in antibiotic induced toxic optic neuropathies[J]. Curr Eye Res, 2018, 43(10): 1199-1204.
|
| [44] |
Grzybowski A, Zülsdorff M, Wilhelm H, et al. Toxic optic neuropathies: an updated review[J]. Acta Ophthalmol, 2015, 93(5): 402-410.
|
| [45] |
Heaton JM, Mc CA, Freeman AG. Tobacco amblyopia: a clinical manifestation of vitamin-B12 deficiency[J]. Lancet, 1958, 2(7041): 286-290.
|
| [46] |
Freeman AG. Optic neuropathy and chronic cyanide intoxication: a review[J]. J R Soc Med, 1988, 81(2): 103-106.
|
| [47] |
Silvette H, Haag HB,，Larson PS. Tobacco amblyopia, the evolution and natural history of a "tobaccogenic" disease[J]. Am J Ophthalmol, 1960, 50: 71-100.
|
| [48] |
Johns DR, Heher KL, Miller NR, et al. Leber′s hereditary optic neuropathy. Clinical manifestations of the 14 484 mutation[J]. Arch Ophthalmol, 1993, 111(4): 495-498.
|
| [49] |
Foulds WS, Chisholm IA, Pettigrew AR. The toxic optic neuro-pathies[J]. Br J Ophthalmol, 1974, 58(4): 386-390.
|
| [50] |
Harrington DO. Amblyopia due to tobacco, alcohol and nutritional deficiency. Differential diagnosis with special reference to the character of the visual field defect[J]. Am J Ophthalmol, 1962, 53: 967-972.
|
| [51] |
Sharma P, Sharma R. Toxic optic neuropathy[J]. Indian J Ophthalmol, 2011, 59(2): 137-141.
|
| [52] |
Kerrison JB. Optic neuropathies caused by toxins and adverse drug reactions[J]. Ophthalmol Clin North Am, 2004, 17(3): 481-488.
|
| [53] |
Kupersmith MJ, Weiss PA, Carr RE. The visual-evoked potential in tobacco-alcohol and nutritional amblyopia[J]. Am J Ophthalmol, 1983, 95(3): 307-314.
|
| [54] |
Salmon JF, Carmichael TR, Welsh NH. Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy[J]. Br J Ophthalmol, 1987, 71(3): 192-196.
|
| [55] |
Gonçalves A, Goufo P, Barros A, et al. Cowpea (Vigna unguiculata L. Walp), a renewed multipurpose crop for a more sustainable agri-food system: nutritional advantages and constraints[J]. J Sci Food Agric, 2016, 96(9): 2941-2951.
|
| [56] |
姚云艳，王静，曹维强. 豆角中毒素中毒机理的研究[J]. 食品科技，2006，31(8)：280-283.
|
| [57] |
Freeman AG. Optic neuropathy and chronic cyanide toxicity[J]. Lancet, 1986, 1(8478): 441-442.
|
| [58] |
Zeboulon P, Vignal-Clermont C, Baudouin C, et al. A rare cause of optic neuropathy: Cassava[J]. J Fr Ophtalmol, 2016, 39(6): 506-514.
|